Derisking Expertise MBI is renowned for its derisking process in industrial biotechnology, offering milestone-based, stage-gated development to quickly filter viable biobased fuels, chemicals, and biomaterials. This presents a sales opportunity to offer collaboration on de-risked pilot pathways and cost-effective scale-up services for partners seeking faster commercialization.

University Industry Bridge As a mission-driven nonprofit affiliated with Michigan State University and serving as a bridge between academia and industry, MBI collaborates with universities, corporations, and research centers. Engage to position your organization as a proven partner for technology transfer, co-development, and sponsored research programs.

Sustainable Biotech Focus MBI’s portfolio emphasizes renewable biobased fuels, chemicals, food, and feed, with a track record of developing technologies like PLA in collaboration with MSU and Cargill. This indicates opportunities for sales in sustainable materials, bio-based product licenses, and joint development agreements aligned with ESG goals.

Scale-Up Capabilities The organization supports moving technologies from lab to bench and pilot scales with integrated science, engineering, and business expertise. A compelling angle for selling process development, pilot plant access, testing services, and scalable manufacturing optimization for early-stage tech entrants.

Strategic Partnerships MBI has a broad network with major players such as DuPont, Novozymes, NatureWorks, and Great Lakes Bioenergy Center. This network suggests opportunities to collaborate on large-scale projects, technology licensing, and access to a wide industrial ecosystem for co-funded initiatives.